Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-44
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche

About this trial

The goal of this interventional study is to measure medial vastus inhibition and associate it with AMI classification in patients with ACL rupture. The main question it aims to answer is:

Is there a correlation between AMI classification and clinical assessment after ACL rupture ? Participants will undergo surface EMG and Myotonometry.

Eligibility criteria

Qualifiers

Patient, male or female, aged ≥ 18 years and < 45 years

Patient with an ACL rupture confirmed by MRI

Patient with an ACL rupture ≤ 30 days old

French speaking patient who does not object to the use of his/her data

Disqualifiers

Patient with previous ipsi or contralateral knee injury/surgery

Patient with multi-ligament injury

Pregnant or breastfeeding woman

Trial design

Treatments tested in this trial

  • Clinical testing

Treatment groups

90 Participants
are divided into 1 treatment group